The cannabis industry is not monolithic, with distinct interests on either side of the THC regulatory divide. Marijuana stakeholders resent the regulatory advantage that hemp operators have. Intoxicants like delta-8 THC are far more profitable than highly regulated and specially taxed flower or delta-9 THC type extracts. Some states are regulating and taxing hemp-derived cannabinoids, but others are taking a laissez-faire approach to this product category.
In active state cannabis markets like California, Oregon, and Colorado, delta-8 THC faced far stronger headwinds than states with no legal marijuana markets. Even smokable hemp saw early aggressive pushback by cannabis lobby in California, a product with no purported intoxicating benefits.
11.21.2024
Domestic US biodiesel blending helps lift October RFS RIN production
US domestic biodiesel blending of 147.5 million gallons in October produced a monthly high of 221.2 million renewable identification number (RIN) credits for January-October. This was 11.5% above September...
11.21.2024
CWG trades lower as broader animal fats markets hold steady
The US animal fats and oils markets held steady on Thursday November 21, with limited trading as attention shifted toward broader macroeconomic factors and...
11.21.2024
October commercial cattle, hog production above 2023
US animal protein prices were steady on Thursday November 21. Limited trade was reported from market sources due to the proximity of the extended Thanksgiving holiday weekend in the...